Abstract
Background The oral cavity harbours a large number of bacterial species as normal flora existing as biofilm. Dental disease such as dental caries results when there is a shift in the balance of bacteria towards pathogenic species within these biofilms.
Objective The objective of this study was to isolation, identification and characterisation of oral bacterial species of patients with dental caries and caries-free healthy control subjects.
Materials and Methods A standard bacteriological procedures were followed in the isolation of bacteria. The identification of bacteria was carried out using matrix-associated laser desorption ionisation–time of flight–mass spectrometry (MALDI–TOF–MS) (Bruker MALDI Biotyper system). The characterisation of bacteria involved in the determination of biofilm forming potential and assessment of synergistic antimicrobial action of manuka honey and gentamicin against the oral species.
Results A total of 13 bacterial species were isolated from 35 orals samples (10 from patients with dental caries); of which seven bacterial species have been isolated for the first time in Saudi Arabia. The Streptococcus spp. exhibited varied biofilm-forming potential and response to synergistic antimicrobial activity of manuka honey and gentamicin.
Conclusion The isolation of seven bacterial species for the first time from dental caries and caries-free subjects in Saudi Arabia warrants a larger prevalence study involving molecular and phenotypic tests to assess their role in health and disease in Saudi population.
Keywords
References
Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev. 2000;13:547–558.
Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167–193.
Samaranayake LP. Normal oral flora, the oral ecosystem and plaque biofilm: essential microbiology for dentistry. Elsevier: Philadelphia; 2006. pp. 255–266.
Marsh PD. Dental plaque as a biofilm and a microbial community: implications for health and disease. BMC Oral Health. 2006;6:S14.
Mendelson MH, Gurtman A, Szabo S, Neibart E, Meyers BR, Policar M, et al. Pseudomonas aeruginosa bacteremia in patients with AIDS. Clin Infect Dis. 1994;18:886–895.
Deep A, Chaudhary U, Gupta V. Quorum sensing and bacterial pathogenicity: from molecules to disease. J Lab Physicians. 2011;3:4–11.
Rahal JJ. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis. 2006;43:S95–S99.
Karayil S, Deshpande SD, Koppikar GV. Effect of honey on multidrugresistant organisms and its synergistic action with three common antibiotics. J Postgrad Med. 1998;44:93–96.
Al-Jabri AA, Al-Hosni SA, Nzeako BC. Antibacterial activity of Omanihoney alone and in combination with gentamicin. Saudi Med J. 2005;26:767–771.
Mukherjee S, Chaki S, Das S, Sen S, Dutta SK, Dastidar SG. Distinct synergistic action of piperacillin and methylglyoxal against Pseudomonas aeruginosa. Indian J. Exp. Biol. 2011; 49: 547–51.
Jenkins RE, Cooper RA. Synergy between oxacillin and manuka honey sensitizes methicillin-resistant Staphylococcus aureus to oxacillin. J Antimicrob Chemother. 2012;67:1405–1407.
van Veen SQ, Claas ECJ, Kuijper EdJ. High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories. J Clin Microbiol. 2010;48:900–907.
Wieser A, Schneider L, Jung J, Schubert S. MALDI–TOF–MS in microbiological diagnostics: identification and beyond. J Appl Biotechnol. 2010;93:965–974.
Moskowitz SM, Foster JM, Emerson J, Burns JL. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol. 2004;42:1915–1922.
Pilhstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366:1809–1820.
Selwitz RH, Ismail AI, Pitts NB. Dental caries. Lancet. 2007;369: 51–59.
Zaura E, Keijser BJ, Huse SM, Crielaard W. Defining the healthy core microbiome of oral microbial communities. BMC Microbiol. 2009;9:259.
Bik EM, Long CD, Armitage GC, Loomer P, Emerson J, Mongodin EF, et al. Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J. 2010;4:962–974.
Amoroso P, de Ávila FA, Gagliardi CMO. Prevalence of different Streptococci species in the oral cavity of children and adolescents. Braz J Oral Sci. 2003;2:164–168.
Gross EL, Beall CJ, Kutsch SR, Firestone ND, Leys EJ, Griffen AL. Beyond Streptococcus mutans: dental caries onset linked to multiple species by 16S rRNA community analysis. PLoS ONE. 2012;7:e47722.
Thurnheer T, Gmur R, Giertsen E, Guggenheim B. Automated fluorescent in situ hybridization for the specific detection and quantification of oral streptococci in dental plaque. J Microbiol Methods. 2001;44:39–47.
Sanchez MC, Llama-Palacios A, Blanc V, León R, Herrera D, Sanz M. Structure, viability and bacterial kinetics of an in vitro biofilm model using six bacteria from the subgingival microbiota.
J Periodont Res. 2011;46:252–260.
Wecke J, Kersten T, Madela K, Moter A, Gobel UB, Friedmann A, et al. A novel technique for monitoring the development of bacterial biofilms in human periodontal pockets. FEMS Microbiol Lett. 2000;191:95–101.
Khan ST, Ahmad J, Ahamed M, Musarrat J, Al-Khedhairy AA. Zinc oxide and titanium dioxide nanoparticles induce oxidative stress, inhibit growth, and attenuate biofilm formation activity of Streptococcus mitis. J Biol Inorg Chem. 2016;21(3):295–303.
Refbacks
- There are currently no refbacks.
Copyright (c) 2016 Journal of Pharmaceutical and Biomedical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.